Overview
Status
Active
Registry date
2020-01-17
Share capital
5,000.00 PLN
Registered address
ul. Grzybowska 80/82/700, 00-844 Warszawa, Poland
Electronic delivery address
AE:PL-46963-62016-AJHRW-32
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 497 days for 2021), 1 not filed.
- 202515/07/2026
- 202410/07/2025
- 202316/07/2024
- 2022not filed
- 202124/11/2023
- 202018/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 116.26kMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD -65.57kMedianUSD 37.33kAverageUSD 879.18k
Operating costs
This companyUSD 172.16kMedianUSD 926.31kAverageUSD 21.06m
Assets
This companyUSD 350.71kMedianUSD 609.81kAverageUSD 11.84m
Industry
Authorized Representatives
Dariusz Jan Malach – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Daniel Marek Malachage 34 | 50 | $675.31 | 50% |
Jan Franciszek Malachage 59 | 50 | $675.31 | 50% |
Daniel Marek Malach and Jan Franciszek Malach hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-02-01.
31 1090 2851 0000 0001 4462 2576
43 1090 2851 0000 0001 4462 2748
02 1600 1114 1860 7462 8000 0002
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl | ||
| Optimedussp. z o.o. | $1.00 | optimedus.pl |
FAQ
The main business activity of Silam focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on January 17, 2020.
The headquarters is located at: ul. Grzybowska 80/82, 00-844 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $116,262, representing a decrease of 23.8% compared to 2024.
No, in 2025 the company was not profitable, reporting a net loss of $65,565. For comparison, in 2024 the loss was $38,279, meaning the company increased its loss by 70.9%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $113,919 in 2025, representing 66% of all operating expenses.
Last updated: 2026-07-16